Issue 4/2011
Content (12 Articles)
Pseudomyxoma peritonei: a rare disease and a disease model in peritoneal surface oncology
Santiago González-Moreno
Fanconi anaemia: from a monogenic disease to sporadic cancer
Antonio Valeri, Sandra Martínez, José A. Casado, Juan A. Bueren
RANKL inhibition: a promising novel strategy for breast cancer treatment
Eva González-Suárez
Glioblastoma: changing expectations?
Leoncio Arribas Alpuente, Antonio Menéndez López, Ricardo Yayá Tur
Oncology outside hospital: a new experience for the benefit of longer survivors
Carlos Camps, Vega Iranzo, Cristina Caballero, Ana Blasco, María José Godes, María José Safont, Sergio Blasco, Gloria Mengual, Alfonso Berrocal, Rafael Sirera
Phase I/II docetaxel plus concurrent hyperfractionated radiotherapy in locally advanced unresectable head and neck cancer (TAX.ES1.102 study)
Agustí Barnadas, Ricard Mesía, Margarita Majem, Ramón Galiana, Antonio López-Pousa, José M. de Vega, Mireia Margelí, Vicente Valentí, Lluís Anglada, Ariadna Lloansí, Antonio Arellano
Pseudomyxoma peritonei treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: results from a single centre
Álvaro Arjona-Sánchez, Francisco C. Muñoz-Casares, Sebastián Rufián-Peña, Rafael Díaz-Nieto, Ángela Casado-Adam, María J. Rubio-Pérez, Rosa Ortega-Salas
Helical tomotherapy in patients with breast cancer and complex treatment volumes
Ricardo Cendales, Luis Schiappacasse, Franco Schnitman, Graciela García, Hugo Marsiglia
Interleukin-15 enhances T-cell responses by stimulation with dendritic cells
Yu Zhao, Ke Cheng, Yang Wu, Xing-Chen Peng, Ye Chen, Ben-Xu Tan, Jun Ge, Hang Dong, Meng Wei, Feng Gao, Jing-Mei Su, Jian-Mei Hou, Ji-Yan Liu
Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000–02 phase II study
Antonio Antón, Agustí Barnadas, Jesús Florián, Nuria Ribelles, María Lomas, Juan Lao, Ana González-Quintás, Mireia Margelí, Ana Belén Paules, Javier Gayo, Manuel Ramos